| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | 1 | 1 | — | — | — | — | — | — |
| Sell | — | — | — | — | — | — | — | — | — | — | 1 | — |
| total | individual payouts | |
|---|---|---|
| 2025 | ‡‡‡ |
|
| 2024 | ‡‡‡ |
|
| 2023 | ‡‡‡ |
|
| 2022 | ‡‡‡ |
|
| 2021 | ‡‡‡ |
|
| 2020 | ‡‡‡ |
|
| 2019 | ‡‡‡ |
|
| 2017 | ‡‡‡ |
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 118.81 | 42.29 | 76.82 | 72.31 |
| Receivables | 3.99 | 16.81 | 7.69 | 1.82 |
| Inventory | — | — | — | — |
| Other | — | — | — | — |
| 122.81 | 59.09 | 84.50 | 74.13 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 7.20 | 23.45 | 28.32 | 2.95 |
| ST’ Debt | — | — | — | — |
| Other | — | — | — | — |
| 68.34 | 83.95 | 85.51 | 20.61 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡ | ‡‡‡ | ‡‡‡ |
| Earnings | ‡‡‡ | ‡‡‡ | ‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 88.02 | 33.57 | — | — |
—
|
| ’25 | 113.12 | 60.78 | 53.87 | 326.24 |
554.01
|
| ’24 | 92.96 | 65.86 | 58.41 | 315.18 |
532.41
|
| ’23 | 73.72 | 66.77 | 64.72 | 247.66 |
452.87
|
| ’22 | 105.25 | 50.41 | 53.38 | 196.32 |
405.36
|
| ’21 | 134.21 | 96.56 | 63.91 | 243.51 |
538.20
|
| ’20 | 106.41 | 88.77 | 94.28 | 293.32 |
582.77
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 35.77 | (4.95) | — | — |
—
|
| ’25 | 77.12 | (41.20) | (25.31) | (35.95) |
(25.34)
|
| ’24 | 70.76 | (32.18) | (29.28) | (27.66) |
(18.37)
|
| ’23 | 60.80 | (9.43) | (24.68) | (33.39) |
(6.69)
|
| ’22 | 47.11 | (25.77) | (29.64) | (18.58) |
(26.87)
|
| ’21 | 42.81 | (32.08) | (71.05) | (102.30) |
(162.62)
|
| ’20 | 8.91 | (21.30) | 1.44 | (96.90) |
(107.86)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 33.46 | (7.64) | — | — |
—
|
| ’25 | 73.70 | (47.05) | (28.94) | (38.36) |
(40.65)
|
| ’24 | 68.27 | (35.04) | (33.47) | (30.98) |
(31.22)
|
| ’23 | 58.57 | (11.77) | (28.89) | (35.38) |
(17.47)
|
| ’22 | 42.85 | (30.11) | (33.76) | (21.35) |
(42.37)
|
| ’21 | 37.67 | (36.99) | (77.14) | (107.01) |
(183.48)
|
| ’20 | 2.84 | (27.51) | (4.82) | (102.12) |
(131.62)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (0.58) | (1.18) | — | — |
—
|
| ’25 | (0.33) | (0.98) | (1.46) | 2.06 |
(0.34)
|
| ’24 | (0.96) | (1.33) | (1.83) | 2.51 |
(1.19)
|
| ’23 | (1.01) | (1.18) | (1.68) | 1.27 |
(2.37)
|
| ’22 | (1.46) | (1.65) | (1.72) | 0.41 |
(4.36)
|
| ’21 | (0.03) | (0.86) | (2.24) | (1.45) |
(4.59)
|
| ’20 | 0.13 | (0.13) | (0.55) | 2.20 |
1.68
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 2.67 | 4.65 | 3.58 | 3.18 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 27.89 | 10.57 | 9.45 | 11.36 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,515 | 1,903 | 1,773 | 1,665 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.27 | 0.24 | 0.30 | 0.33 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 405.36 | 452.87 | 532.41 | 554.01 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 99.59% | 99.61% | 100.00% | 100.00% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (106.39) | (30.59) | 19.31 | 58.73 | ‡‡‡‡‡ | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (26.25%) | (6.76%) | 3.63% | 10.60% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (88.72) | (28.21) | 10.06 | 40.04 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 21.11 | 19.92 | 16.34 | 13.76 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 14.82 | 16.16 | 18.15 | 18.17 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | (4.36) | (2.37) | (1.19) | (0.34) | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.98) | (0.24) | (0.63) | (0.83) | ‡‡‡‡ | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.57) | (0.38) | (0.44) | (0.50) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.55) | (0.62) | (1.06) | (1.33) | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 23.79 | 21.63 | 20.06 | 19.41 | ‡‡‡‡‡ | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 27.36 | 28.02 | 29.34 | 30.48 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | 0.00 | 0.00 | 0.00 | 0.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.33 | 0.53 | 0.52 | 0.25 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.20 | 0.39 | 0.47 | 0.24 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.14 | 0.43 | 0.70 | 0.44 | ‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.22) | (8.88) | (10.37) | (5.44) | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (26.87) | (6.69) | (18.37) | (25.34) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (15.51) | (10.78) | (12.86) | (15.31) | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (42.37) | (17.47) | (31.22) | (40.65) | ‡‡‡‡‡ | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 99.08 | 54.47 | (24.85) | (1.01) | — | — | — |
Working Cap'
|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 72.13 | 67.75 | 68.46 | 112.95 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (75.51) | (51.06) | 26.17 | 36.14 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 650.96 | 606.03 | 588.43 | 591.60 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (10.56%) | (5.98%) | (3.08%) | (0.86%) | ‡‡‡‡‡ | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (11.16%) | (3.27%) | 2.40% | 6.62% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (17.05%) | (10.58%) | (5.85%) | (1.76%) | ‡‡‡‡‡ | — | — |
ROE
|
eHealth, Inc. (EHTH), a leader in online health insurance marketplaces, has endured a boom-bust cycle fueled by ACA expansions, COVID enrollment surges, and fierce competition from giants like UnitedHealth. Revenues skyrocketed from $193 million in 2016 to a $583 million peak in 2020 before contracting amid post-pandemic normalization, rebounding to $532 million in 2024 with standout gross margins above 99.5%—a digital brokerage edge in the $1.5 trillion U.S. health insurance sector. Trading at deeply depressed levels (down 82% from 2024 highs), shares face macro headwinds like 4-5% annual healthcare inflation, elevated Fed rates inflating debt costs, and regulatory shifts, yet analyst targets signal explosive upside: average 400%, high-end over 600%.
Profitability remains volatile, with 2019 net income of $67 million swinging to losses through 2023 before a modest 2024 profit; forecasts predict deeper 2025-2026 reds before 2027 recovery amid efficiency gains (revenue per employee rebounding to $300,000). Cash flow pressures persist via FCF burns and share dilution, though manageable net debt ($26 million) and a resilient balance sheet (equity $588 million) provide a buffer. Insider confidence shines with a recent buy and zero sells, contrasting capitulation lows in this high-risk insurtech turnaround.
Looking ahead, modest revenue growth (+3-6%) aligns with stabilizing operations, Medicare enrollment booms (+10% by 2030 per CMS), potential Fed cuts, and ACA enhancements, potentially driving FCF positivity and multiple expansion from today’s 0.5x P/S (vs. 4.4x peak). Risks include execution stumbles and carrier consolidations, but at current valuations, EHTH offers speculative deep value in a maturing sector—watch Q1 2026 enrollments for inflection signals.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.